P776: A PHASE 2, OPEN-LABEL, ASCENDING DOSE STUDY OF KER-050 FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES by S. Tan, A. Arbelaez, L. Chee, C. Y. Fong, D. Hiwase, G. Kannourakis, J. Kwan, J. Liang, A. Puliyayil, H. Rose, D. Ross, T.-C. Teh, D. Westerman, J. Wight, W. Feng, J. Lachey, A. McGinty, H. Natarajan, C. Rovaldi, S. Cooper

Get full text